| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
102,087,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
3,941,702 |
Avg
Vol: |
1,828,512 |
| 52
Week Range: |
$45.85 - $45.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pauwels Eric |
President, NPS Pharma Intl |
• – – |
2014-08-01 |
4 |
D |
$27.86 |
$17,273 |
D/D |
(620) |
29,951 |
|
- |
|
| Pauwels Eric |
President, NPS Pharma Intl |
• – – |
2014-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,667 |
30,571 |
|
- |
|
| Graf Susan E |
VP,Corp Development & Strategy |
• – – |
2014-06-17 |
4 |
D |
$33.10 |
$65,803 |
D/D |
(1,988) |
3,800 |
|
- |
|
| Graf Susan E |
VP,Corp Development & Strategy |
• – – |
2014-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,788 |
5,788 |
|
- |
|
| Firuta Paul E |
Pres, US Commercial Operations |
• – – |
2014-03-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
300 |
|
- |
|
| Granadillo Pedro P |
Director |
– • – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,188 |
30,413 |
|
- |
|
| Melrose Glenn R |
SVP, Human Resources |
• – – |
2014-02-13 |
4 |
D |
$38.30 |
$82,920 |
D/D |
(2,165) |
26,971 |
|
- |
|
| Melrose Glenn R |
SVP, Human Resources |
• – – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,075 |
29,136 |
|
- |
|
| Nader Francois |
President, CEO and Director |
• • – |
2014-02-13 |
4 |
D |
$38.30 |
$450,676 |
D/D |
(11,767) |
233,656 |
|
- |
|
| Nader Francois |
President, CEO and Director |
• • – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,301 |
245,423 |
|
- |
|
| Selisker Rachel R |
Director |
– • – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,188 |
25,088 |
|
- |
|
| Garceau Roger |
SVP & CMO |
• – – |
2014-02-13 |
4 |
D |
$38.30 |
$150,213 |
D/D |
(3,922) |
67,832 |
|
- |
|
| Garceau Roger |
SVP & CMO |
• – – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,530 |
71,754 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2014-02-13 |
4 |
D |
$38.30 |
$209,080 |
D/D |
(5,459) |
59,602 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,530 |
65,061 |
|
- |
|
| Rogus Joseph J |
VP, Technical Operations |
• – – |
2014-02-13 |
4 |
D |
$38.30 |
$40,636 |
D/D |
(1,061) |
20,151 |
|
- |
|
| Rogus Joseph J |
VP, Technical Operations |
• – – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,240 |
21,212 |
|
- |
|
| Groninger James G |
Director |
– • – |
2014-02-13 |
4 |
AS |
$37.70 |
$226,200 |
D/D |
(6,000) |
9,938 |
|
- |
|
| Groninger James G |
Director |
– • – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,188 |
15,938 |
|
- |
|
| Gemayel Georges |
Director |
– • – |
2014-02-13 |
4 |
AS |
$37.70 |
$233,288 |
D/D |
(6,188) |
9,000 |
|
- |
|
| Gemayel Georges |
Director |
– • – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,188 |
15,188 |
|
- |
|
| Stratemeier Ed |
SVP & General Counsel |
• – – |
2014-02-13 |
4 |
D |
$38.30 |
$74,723 |
D/D |
(1,951) |
44,253 |
|
- |
|
| Stratemeier Ed |
SVP & General Counsel |
• – – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,670 |
46,204 |
|
- |
|
| Broom Colin Md |
Director |
– • – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,188 |
24,313 |
|
- |
|
| Pauwels Eric |
SVP & Chief Commercial Officer |
• – – |
2014-02-13 |
4 |
D |
$38.30 |
$108,312 |
D/D |
(2,828) |
28,904 |
|
- |
|
574 Records found
|
|
Page 4 of 23 |
|
|
